Skip to main content
Caplight Logo









Xiamen LP Pharmaceutical Co., Ltd.

Xiamen LP Pharmaceutical Co., Ltd.

Private
XiamenHealthcare & Life Scienceshttps://lppharma.com/

Last Round

Series C

Aug 19, 2020

Est. Valuation

$288.18M

Total Funding Raised

$102.35M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Xiamen LP Pharmaceutical Co., Ltd. is a pharmaceutical company that develops and manufactures innovative clinical drugs and advanced drug delivery systems for various therapeutic areas.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

active pharmaceutical ingredientsAPIpharmaceutical intermediatesfine chemicalscontract manufacturing organizationCMOchemical synthesisdrug developmentpharma supply chaincustom synthesischemical supplierCDMObulk chemical supply

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xiamen LP Pharmaceutical Co., Ltd. Comparables

Compare Xiamen LP Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.

Xiamen LP Pharmaceutical Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Jinan Qinmu Fine Chemical Co., Ltd.
82%
Sandoo Pharmaceuticals and Chemicals Co., Ltd.
81%
Suzhou Lixin Pharmaceutical Co., Ltd.
79%

Xiamen LP Pharmaceutical Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CAug 19, 2020
Series BDec 19, 2017
Series AAug 1, 2015

Xiamen LP Pharmaceutical Co., Ltd. Investors

Notable investors and investment history

Xiamen LP Pharmaceutical Co., Ltd. investors
InvestorRounds
Hankang CapitalSeries A
DYEE CapitalSeries C
Qiandao FundSeries C
SDIC Innovation Investment ManagementSeries B
HongShan Capital Group (HSG)Series C
Industrial Bank Co., Ltd.Series C
Shenzhen Capital GroupSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 2753% MoM.

  • Jan 25, 2025

    Monthly visitors grew 144% MoM, reaching 1.7K.

Xiamen LP Pharmaceutical Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Xiamen LP Pharmaceutical Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Xiamen LP Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersXiamen
Employee Range3
Year Founded2012
Last FundingAug 19, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?